INTRODUCTION
Genetic defects are important in the etiology of sensorineural hearing impairment (HI) especially in the early onset cases. 1 Hereditary sensorineural HI is nonsyndromic (NSHI) in the majority of early onset cases, but part of these will be diagnosed with syndromic HI later in life. Usher syndrome is the most common sensorineural HI syndrome with a prevalence of 3-6.2 per 100 000 and the first symptoms of retinitis pigmentosa most often in the first or second decade of life. 2 Vestibular defects occur in part of the subjects with Usher syndrome and lead to delayed motor development. 2 To date, there are 13 loci and 10 genes known to be involved in the three clinical types of Usher syndrome. [3] [4] [5] [6] Mutations in six of these genes, MYO7A, 7-10 CDH23, 11,12 PCDH15, 13,14 WHRN, 15,16 SANS 17 and CIB2, 4 can lead to either Usher syndrome or autosomal recessive NSHI (arNSHI). Mutations in USH2A can lead to either Usher syndrome or nonsyndromic retinitis pigmentosa. 18, 19 CIB2 belongs to a family of calcium and integrin-binding proteins. CIB2 contains three predicted EF hand domains, of which only the two most C-terminal EF hands are able to bind Ca 2+ . 20, 21 Upon Ca 2+ binding, conformational changes occur that create a hydrophobic pocket that mediates the interaction with the C-terminal tail of integrin. 22, 23 CIB2 has a broad expression pattern that includes the inner ear where it is immunohistochemically detected in supporting cells and in stereocilia and cuticular plate of hair cells in the cochlea and the vestibular system. 4 Based on the functional impairment of hair cells in Cib2 zebrafish morphants, it has been suggested that Cib2 is important for Ca 2+ homeostasis in sensory hair cells, and that loss of Cib2 function might affect processes like mechanotransduction, adaptation, electromotility and synaptic transmission. 4, 24 Similarly, through functional studies in Drosophila, CIB2 was found to be essential for adequate phototransduction and maintenance of photoreceptor cells. 4 Furthermore, CIB2 has been demonstrated to be integrated into the Usher interactome via the association with whirlin and myosin VIIa. 4 In this study, we present molecular identity of functional variants in CIB2 in NSHI-affected families of Dutch and Pakistani origin ( Figure 1) . One is the recurrent c.272T4C CIB2 missense variant 4 present homozygously in two Pakistani families with moderate-tosevere and profound prelingual arNSHI, respectively. The second is the novel c.196C4T missense variant found homozygously and in compound heterozygous state with the c.97C4T nonsense variant in two families of Dutch origin with profound arNSHI. We analyzed the effect of these deafness-associated alleles on the expression, subcellular localization and calcium binding abilities of CIB2.
MATERIALS AND METHODS

Patients and their clinical and audiological evaluation
The current study conformed to the tenets of the Declaration of Helsinki Principles. Informed consent was obtained from all participating subjects of two families from Pakistan W09-1575 and W09-1600 (Figure 1a) , and from the Dutch families W06-0987 and 07-1069 (Figures 1b and c) . This study was approved by the Department of Biosciences Ethics Review Board of the COMSATS Institute of Information Technology, Islamabad, Pakistan, and the local ethics committee of the Radboud university medical center, Nijmegen, The Netherlands.
In all four families, other possible causes of HI, previous ear surgery and external ear deformities were excluded by a general ENT examination. In addition, a computed tomography (CT) scan of the temporal bone was performed for the affected individual of family W06-0987 and one affected III:11  III:10  III:9  III:8  III:7  III:6  III:5  III:4  III:3  III:2  III:1   II:3  II:2   I:2  I:1   II:1   II:1  II:2  II:3   III:3  III:4   II:7  II:6  II: CIB2 variants do not affect Ca 2+ and localization CZ Seco et al member (II.1) of family 07-1069 in order to exclude possible anatomical causes of HI. Pure tone audiometry was performed to determine hearing thresholds at 0.25, 0.5, 1, 2, 4 and 8 kHz. Both air-and bone-conduction thresholds were obtained to exclude a conductive hearing loss. Brainstem-evoked response audiometry (BERA) was performed for the affected individual of family W06-0987 and individual II.1 of family 07-1069 according to current standards. Visual reinforcement audiometry (VRA) was performed before the age of 3 years in the affected individual of family W06-0987. 25 GraphPad Prism 5.00 (GraphPad, San Diego, CA, USA) was employed for linear regression analysis to evaluate whether or not HI in family W06-0987 was progressive. Classification of the HI is in accordance with the GENDEAF guidelines (Hereditary Hearing Loss Homepage). For families W06-0987 and 07-1069 vestibular function was assessed by electronystagmography, rotatory tests and calorisation as previously described. 26 To evaluate retinal involvement in the disease, fundoscopy was performed. In addition, renal, liver and thyroid functions were assessed in family W06-0987.
Genetic studies and functional evaluation of variants
Genomic DNA was isolated from peripheral blood lymphocytes by standard procedures. DNA of individual II.3 from family W06-0987 was genotyped with the Affymetrix GeneChip Human Mapping 250 K Nsp SNP array according to the manufacturer's protocol. Genotype calling and calculation of the regions of homozygosity was performed with the Genotyping Console software (Affymetrix, Santa Clara, CA, USA) and default settings. For families W09-1575 (IV:2, IV:6, IV:8 and V:4) and W09-1600 (III:1, III:4, III:8 and III:9), genotyping with Illumina HumanOmniExpress 700 K arrays was performed (San Diego, CA, USA). Homozygous regions were determined using the online tool Homozygosity Mapper with default settings. All exons of CIB2 including exon-intron boundaries were analyzed for the presence of variants as previously described, 4 employing NM_006383.2 as reference sequence. Mutation analysis of TRIOBP was performed by Sanger sequencing. 27 Primer sequences are available upon request. As a reference sequence NM_001039141.2 and NM_138632.2 were employed.
For affected member II.1 of family 07-1069, mutations and the common deletion in the GJB2 associated with DFNB1 have been excluded by Sanger sequencing and allele-specific PCR. Other known mutations in genes associated with severe congenital hearing loss, that is, CDH23, MYO7A, PCDH15, USH1C, USH1G, USH2A, GPR98, USH3A and DFNB31, were excluded by using the Asper Biotech array (version 6.0 with 612 variants) for Usher syndrome (Asper Biotech, Tartu, Estonia). Subsequently, variants in a set of 104 deafness genes (URL Gene list) were identified by whole-exome sequencing followed by data filtering and interpretation. Library preparation was performed using 3 μg of purified DNA of affected member II.1 of family 07-1069. For enrichment, the SOLiD optimized Sure Select All Human Exon Kit (50 Mb; Agilent Technologies, Santa Clara, CA, USA) was employed, followed by sequencing on 5500XL sequencers (Life Technologies, Carlsbad, CA, USA). Sequence reads were aligned to the human genome (hg19) using Lifescope v2.1 (Life Technologies), followed by variant calling on the aligned sequence. Variants were annotated using a custom analysis pipeline. 28 The criteria to filter and interpret variants in the set of 104 genes known to be associated with deafness was as described previously. 28, 29 An in-house-developed graphical user interface was used for data visualization and filtering within the respective gene set.
Molecular modeling, expression of CIB2 in hair cells by Helios gene gun transfection and calcium response assays of DsRed-tagged CIB2 Phe91Ser , CIB2 Arg66Trp and CIB2 WT were performed as previously described. 4 All variants identified in this study were submitted to the Leiden Open Variant Database with the following IDs: c.97C4T, #05182; c.196C4T, #05182; c.272T4C, #05182.
RESULTS
Patient evaluation
For none of the hearing-impaired individuals additional abnormalities were found during ENT examination. Affected individuals of Pakistani family W09-1575 ( Figure 1a) were diagnosed with prelingual, bilateral, moderate-to-severe sensorineural HI (Figure 2 ). In another Pakistani CIB2 variants do not affect Ca 2+ and localization CZ Seco et al family W09-1600 the HI was profound, prelingual, bilateral and sensorineural ( Figure 2 ). There were no symptoms of retinal degeneration in the hearing-impaired individuals of these two families. 
Genetic analyses
As a first step in the genetic analyses of the presented families, functional variants in GJB2 were excluded through Sanger sequencing, and allele-specific PCR was employed to exclude the common GJB2/ GJB6 deletion. Homozygosity mapping was subsequently performed in families W06-0987, W09-1575 and W09-1600 as part of a larger project directed toward the identification of genetic defects underlying sensorineural HI in consanguineous Pakistani families and nonconsanguineous families of The Netherlands. 27, 30 In the only affected individual II.3 of family W06-0987, homozygosity mapping revealed nine homozygous regions larger than 1 Mb (Table 1 ). The second large homozygous region harbored TRIOBP, the gene associated with the known arNSHI type DFNB28. 31, 32 No variants with a predicted functional effect were identified in TRIOBP by Sanger sequencing of the exons and exon-intron boundaries. The largest homozygous region of 16 Mb (SNP_A-1814998; SNP_A-A-1821537) contained the CIB2 gene, associated with DFNB48 and Usher syndrome type I (USH1J) by allelic functional variants. 4 Genotyped affected individuals of the consanguineous family W09-1575 shared only one homozygous region larger than 3 Mb, which overlapped with the only shared homozygous region larger than 3 Mb in genotyped affected individuals of family W09-1600. CIB2 is located in the overlapping chromosomal segment (Table 1 ). In family W09-1575, an additional homozygous region of 4 Mb (rs1516570; rs12186082) was identified on chromosome 3. However, the affected individuals were homozygous for different alleles. Therefore this region was not further analyzed. Mutation analysis of CIB2 in the affected individual of family W06-0987 revealed a homozygous variant c.196C4T that is predicted to cause a substitution of a tryptophan for arginine (p.(Arg66Trp); Supplementary Figure 1A) . The mother and unaffected sibling were carriers of this variant (Figure 1b) . CIB2 c.196C4T affects all known CIB2 protein isoforms except isoform CIB2-006 as indicated in ENSEMBL (GRCh38) and in the Genome browser (GRCh37; Supplementary Figure 2) . 4 The c.196C4T variant is not present in the NCBI dbSNP138 database, the NHLBI Exome Sequencing Project (Exome Variant Server), the 1000 Genomes Project and the Nijmegen exome database (5031 exomes). In addition, c.196C4T is predicted to have a deleterious effect on protein function according to Polymorphism phenotyping version 2 with a score of 0.98 (range 0-1, 0 being benign and 1 being probably damaging), mutation taster with a score of 0.99 (range 0-1, 0 being benign and 1 being probably damaging) and Sorting Intolerant From Tolerant (SIFT) with a score of 0 ( ≤ 0.05 predicted to be damaging, 40.05 predicted to be tolerated). The c.196C4T missense variant affects the codon for amino-acid residue Arg66 that is moderately conserved with a score of 4 (9; conserved, 1; variable) according to the ConSeq online bioinformatic tool. The arginine residue at position 66 is conserved across the CIB2 orthologs and CIB4 paralogs in a wide range of species. In the paralogs CIB1 and CIB3 and several of the CIB2 orthologs, lysine is found at this position that is, like arginine, a positively charged amino acid (Supplementary figure 1B) .
Sanger sequencing of CIB2 in families W09-1575 and W09-1600 revealed a homozygous missense variant c.272T4C (Supplementary figure 1A) , which is predicted to substitute a serine for a phenylalanine. This functional variant was previously described to be a founder mutation and a common cause of arNSHI in the Pakistani population. 4 Figure 2) . 4 The c.97C4T variant is predicted to result in nonsense-mediated decay, as it introduces a premature termination codon more than 54 bp upstream of the last intron. 33 The c.196C4T and c.272T4C variants do not affect targeting of CIB2 to the stereocilia tip of vestibular hair cells CIB2 is localized along the stereocilia of cochlear and vestibular hair cells, as well as at the stereocilia tips. 4 The mechanism that permits the targeting of CIB2 to the region of the mechanotransduction machinery is still unclear. We transiently overexpressed a CIB2 Arg66Trp -GFP and CIB2 Phe91Ser -GFP constructs in P2 vestibular system explants in order to investigate their effect on CIB2 targeting. We found that, like wild-type control (CIB2 WT -GFP), CIB2 Arg66Trp -GFP, as well as CIB2 Phe91Ser -GFP, accumulate in the cuticular plate, along and at the tip of the stereocilia of vestibular hair cells (Figure 3) . These results suggest that, at least ex vivo, the arNSHI-associated variants do not affect CIB2 targeting in vestibular sensory hair cells (Figure 3) . showing that the amino-acid substitutions do not affect the calciumbuffering ability of CIB2 (Figure 4c ).
B and C but not isoforms A and CIB2-006 (Supplementary
Molecular modeling suggests impaired interaction of CIB2 with effector molecules due to the c.196C4T and c.272T4C variants When modeled using the known crystal structure of CIB1 as backbone 4, 21, 34 in CIB2, the p.Arg66 maps to the N-terminal domain of CIB2 within a region that has been implicated in the interaction of CIB protein with the carboxy terminal, unstructured, negatively charged tail of αIIβ integrin. CIB1 is involved in the activation of integrin αIIβ3. It is thought that hydrophobic interactions between the αIIβ helix and the C-terminal domain of CIB1 primarily drive the interaction, with the N-domain involved in electrostatic stabilizing interactions with the negatively charged unstructured C-terminal tail of αIIβ (residues P 998 PLEEDDEEGQ 1008 ). Implicated in this interaction are residues p.Arg33 and p.Lys65 of CIB1. By structure-based sequence alignment this corresponds to p.Arg33 and p.Arg66 of CIB2. Therefore, an amino acid change at p.Arg66 would likely destabilize the interaction with integrin and thus attenuate integrin activation (Figures 4a and b) . 22, 34 In consistence with our calcium-imaging data, Arg66 is located away from the Ca 2+ binding pockets, 20, 21 and thus the substitution of tryptophan for arginine at position 66 is predicted not to alter calcium-buffering abilities of CIB2. Similarly, the substitution of serine for phenylalanine at position 91 is also predicted to weaken the interaction of CIB2 with αIIβ integrin. 4 
DISCUSSION
In this study we present a new homozygous functional variant, c.97C4T, and a compound heterozygous variants, c.
[97C4T]; [196C4T] in CIB2 underlying DFNB48 arNSHI in an isolated case (W06-0987) and in a family (07-1609), respectively, of Dutch origin. Additionally, we report two consanguineous families of Pakistani origin (W09-1575 and W09-1600) with arNSHI carrying the previously described and recurrent CIB2 variant, c.272T4C. Due to this founder variant, defects in CIB2 are the major cause of arNSHI in Pakistan. 4 DFNB48 and USH1J are caused by allelic CIB2 variants. 4 Patients of the so far only family with USH1J present with prelingual, bilateral profound HI. Retinitis pigmentosa in the USH1J family progressed from mild to complete vision loss and was detected as early as 10 years of age. Besides that, vestibular dysfunction, later confirmed by ENG, was suspected as there was a delayed onset of ambulation. 35 The DFNB48 phenotype found in three of the four families reported in the present study is consistent with the previously described DFNB48 phenotype, 4, 36 severe to profound, prelingual bilateral HI without signs of retinitis pigmentosa and vestibular dysfunction. However, the HI in family W09-1575 with the recurrent homozygous variant, is less severe. The age at last evaluation of affected individuals in this family, who were diagnosed in early childhood, varies from 5 to 29 years and there are no signs of progression to profound HI. Genetic modifying factors might contribute to the less severe HI as compared with that in the previously described DFNB48 families. 4 Therefore, it is worthwhile to perform more extensive genotyping in this family in order to identify candidate modifying DNA variants for CIB2 defects, which may provide insight into pathogenic mechanisms.
Interestingly, the c.196C4T variant associated with arNSHI is located very close to the c.192G4C variant associated with the USH1J phenotype. 4 At their most recent evaluation at the ages of 24 years (family W06-0987) and 7 and 4 years (family 07-1069), the hearingimpaired individuals with the c.196C4T variant in the homozygous or compound heterozygous state did not have any symptoms of early retinitis pigmentosa. As electroretinography could not be performed, we cannot exclude an early stage of retinitis pigmentosa in these individuals. However, classical USH1J as diagnosed in the USH1J family with the c.192G4C variant in the homozygous state 4, 35 is excluded in the present families because of the absence of vestibular areflexia, and for family W06-0987, in addition, because of lack of symptoms of retinal degeneration at 24 years of age. 2 The difference in phenotypic effect of the c.192G4C (p.(Glu64Asp)) and c.196C4T (p. (Arg66Trp)) variants in CIB2 might be the result of a larger negative effect of the former mutation because of loss of a salt bridge between residues Arg33 and Glu64, which is formed in the absence of integrin. 4 The associations of CIB2 with the Usher proteins myosin VIIa (USH1B) and whirlin (USH2D) 16 are candidates for being affected differently by the two mutations but so far the region(s) of CIB2 that mediate(s) these direct or indirect interactions is still elusive. The identification of additional USH1J and DFNB48 families can shed light on the underlying reasons for the phenotypic differences, DFNB48 and USH1J, of mutations that affect neighboring amino-acid residues. Phenotypes varying from arNSHI, USH1J and HI combined with a variable age of onset of retinitis pigmentosa or asymptomatic retinitis pigmentosa-like findings has previously been described for functional variants in CDH23. 37 Screening of CIB2 in more families in different populations will add more information on the frequency of functional variants of CIB2 and will contribute to define phenotype-genotype correlations of CIB2 variants.
